Related Experiment Video
Updated: Apr 11, 2026

14:06
Detection of Rare Genomic Variants from Pooled Sequencing Using SPLINTER
Published on: June 23, 2012
15.9K
Rapid Detection of Rare Deleterious Variants by Next Generation Sequencing with Optional Microarray SNP Genotype Data
Christopher M Watson1,2, Laura A Crinnion1,2, Juliana Gurgel-Gianetti3
1School of Medicine, University of Leeds, Leeds, United Kingdom.
Human Mutation
|June 4, 2015
Summary
AgileVCFMapper integrates SNP genotyping and exome sequencing data for efficient disease gene identification. This tool streamlines the analysis of rare, autosomal recessive genetic disorders.
Area of Science:
- Genetics
- Bioinformatics
- Computational Biology
Background:
- Autozygosity mapping is crucial for identifying rare, autosomal recessive disease genes.
- Genome-wide SNP genotyping and exome sequencing have simplified data generation but complicated analysis.
- Integrating disparate data types for genetic analysis remains a significant challenge.
Purpose of the Study:
- To develop a streamlined computational tool for integrated genetic analysis.
- To enable the use of next-generation sequencing variant data for disease locus identification.
- To facilitate the combined analysis of SNP genotyping and exome sequencing data.
Main Methods:
- Developed AgileVCFMapper, a program for simultaneous SNP genotyping and exome sequence variant analysis.
- The method integrates disease locus mapping and variant analysis in a single step.
- AgileVCFMapper can utilize exome sequence variant data independently or in combination with microarray SNP data.
Main Results:
- AgileVCFMapper successfully maps disease loci using both SNP and exome sequence data.
- The program simplifies the complex analysis of genetic data for identifying disease-causing genes.
- Combining microarray and exome data provides more precise disease locus delineation.
Conclusions:
- AgileVCFMapper offers an efficient, integrated approach for identifying genes responsible for rare genetic disorders.
- The tool enhances the utility of next-generation sequencing data in autozygosity mapping.
- This integrated method reduces analysis time and improves the precision of disease gene discovery.
More Related Videos
Related Concept Videos
Next-generation Sequencing
101.9K
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
101.9K
Comparing Copy Number Variations and SNPs
19.4K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
19.4K
Genome-wide Association Studies-GWAS
16.8K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
16.8K

